Patents Assigned to EYECURE THERAPEUTICS, INC. (JIANGSU)
  • Patent number: 11932869
    Abstract: The present invention disclose a method for digesting RPE cells to dissociate adherent cells, comprising steps: (1) using 1× recombinant enzyme TrypLE to cover RpE cells evenly; (2) using neutral protease Dispase II solution to cover RPE cells evenly, in which steps (1) and (2) are applied step by step.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: March 19, 2024
    Assignee: EYECURE THERAPEUTICS, INC. (JIANGSU)
    Inventors: Zhanhai Yan, Lei Xie